Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis

Key Findings

• ●Anti-IL-1 agents significantly reduce attack frequency and inflammatory markers
• ●Both anakinra and canakinumab effective in colchicine-resistant FMF

Referenced in (1 disease)

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.